Pricing
Login
Home
Charts
Search
Watchlist
Products

Abbott India Ltd

ABBOTINDIA
₹26,525.00+3.23%20 Nov 2026
Reports
Pharma MNC Bulk Drugs

Abbott India Ltd

ABBOTINDIA
₹26,525.00
+3.23%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹56,364Cr
Close
Close Price
₹26,525.00
Industry
Industry
Pharma MNC Bulk Drugs
PE
Price To Earnings
34.10
PS
Price To Sales
7.83
Revenue
Revenue
₹7,198Cr
Rev Gr TTM
Revenue Growth TTM
7.21%
PAT Gr TTM
PAT Growth TTM
9.54%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,4371,4391,5581,6331,6141,6051,7381,7571,7241,7101,8141,951
Growth YoY
Revenue Growth YoY%
8.77.15.39.312.311.511.67.66.86.54.311.0
Expenses
ExpensesCr
1,0491,1091,1671,1941,1781,1761,2931,2551,2611,2291,2911,383
Operating Profit
Operating ProfitCr
388330391439436429446502463481523568
OPM
OPM%
27.022.925.126.927.026.725.628.626.928.128.829.1
Other Income
Other IncomeCr
568167607276737070767568
Interest Expense
Interest ExpenseCr
333324685666
Depreciation
DepreciationCr
181818181818191919192019
PBT
PBTCr
422390437479488483493546509531572610
Tax
TaxCr
111103109121127116127131133136144157
PAT
PATCr
311287328359361367366415376395429453
Growth YoY
PAT Growth YoY%
26.024.013.014.616.027.911.515.84.27.617.19.2
NPM
NPM%
21.619.921.122.022.422.921.123.621.823.123.623.2
EPS
EPS₹
146.3135.1154.4168.8169.8172.7172.2195.4176.9185.8201.7213.4
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1,4371,4391,5581,6331,6141,6051,7381,7571,7241,7101,8141,951
Growth YoY
Revenue Growth YoY%
8.77.15.39.312.311.511.67.66.86.54.311.0
Expenses
ExpensesCr
1,0491,1091,1671,1941,1781,1761,2931,2551,2611,2291,2911,383
Operating Profit
Operating ProfitCr
388330391439436429446502463481523568
OPM
OPM%
27.022.925.126.927.026.725.628.626.928.128.829.1
Other Income
Other IncomeCr
568167607276737070767568
Interest Expense
Interest ExpenseCr
333324685666
Depreciation
DepreciationCr
181818181818191919192019
PBT
PBTCr
422390437479488483493546509531572610
Tax
TaxCr
111103109121127116127131133136144157
PAT
PATCr
311287328359361367366415376395429453
Growth YoY
PAT Growth YoY%
26.024.013.014.616.027.911.515.84.27.617.19.2
NPM
NPM%
21.619.921.122.022.422.921.123.621.823.123.623.2
EPS
EPS₹
146.3135.1154.4168.8169.8172.7172.2195.4176.9185.8201.7213.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,6152,9033,2993,6794,0934,3104,9195,3495,8496,4096,9297,198
Growth
Revenue Growth%
14.611.013.611.511.35.314.18.79.39.68.17.2
Expenses
ExpensesCr
2,2502,5052,7743,0743,3373,3893,8324,1434,3964,7155,0375,164
Operating Profit
Operating ProfitCr
3643975256057569211,0881,2061,4531,6951,8922,035
OPM
OPM%
13.913.715.916.418.521.422.122.524.826.427.328.3
Other Income
Other IncomeCr
51581171131148177154248276288289
Interest Expense
Interest ExpenseCr
3242918191612112523
Depreciation
DepreciationCr
141616176058667071727677
PBT
PBTCr
3984366216998039261,0801,2741,6181,8872,0792,223
Tax
TaxCr
143160220249210235281324417473527570
PAT
PATCr
2552774014505936917999491,2011,4141,5521,653
Growth
PAT Growth%
11.58.445.012.231.716.515.618.926.517.89.79.5
NPM
NPM%
9.89.512.212.214.516.016.217.820.522.122.423.0
EPS
EPS₹
120.1130.2188.8211.9279.0325.0375.9446.8565.3665.6730.4777.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,6152,9033,2993,6794,0934,3104,9195,3495,8496,4096,9297,198
Growth
Revenue Growth%
14.611.013.611.511.35.314.18.79.39.68.17.2
Expenses
ExpensesCr
2,2502,5052,7743,0743,3373,3893,8324,1434,3964,7155,0375,164
Operating Profit
Operating ProfitCr
3643975256057569211,0881,2061,4531,6951,8922,035
OPM
OPM%
13.913.715.916.418.521.422.122.524.826.427.328.3
Other Income
Other IncomeCr
51581171131148177154248276288289
Interest Expense
Interest ExpenseCr
3242918191612112523
Depreciation
DepreciationCr
141616176058667071727677
PBT
PBTCr
3984366216998039261,0801,2741,6181,8872,0792,223
Tax
TaxCr
143160220249210235281324417473527570
PAT
PATCr
2552774014505936917999491,2011,4141,5521,653
Growth
PAT Growth%
11.58.445.012.231.716.515.618.926.517.89.79.5
NPM
NPM%
9.89.512.212.214.516.016.217.820.522.122.423.0
EPS
EPS₹
120.1130.2188.8211.9279.0325.0375.9446.8565.3665.6730.4777.8
Sales CAGR
1 Year8%
3 Years9%
5 Years10%
TTM7%
EBITDA CAGR
1 Year12%
3 Years16%
5 Years15%
TTM12%
PAT CAGR
1 Year10%
3 Years18%
5 Years18%
TTM10%
Avg. ROCE
1 Year43%
3 Years43%
5 Years41%
TTM53%
CFO / EBITDA
1 Year70%
3 Years70%
5 Years73%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
212121212121212121212121
Reserves
ReservesCr
1,1741,3661,6721,9872,4102,5812,7993,1673,6784,2124,7534,249
Current Liabilities
Current LiabilitiesCr
3826326688578911,0311,2031,2061,3431,4071,4771,422
Non Current Liabilities
Non Current LiabilitiesCr
39475575224207201161152277251232
Total Liabilities
Total LiabilitiesCr
1,6172,0662,4162,9413,5473,8404,2244,5565,1935,9176,5025,925
Current Assets
Current AssetsCr
1,4511,8932,2652,7613,2053,4873,8533,0253,2464,7633,7713,921
Non Current Assets
Non Current AssetsCr
1661731511803423533711,5301,9481,1542,7312,004
Total Assets
Total AssetsCr
1,6172,0662,4162,9413,5473,8404,2244,5565,1935,9176,5025,925
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
212121212121212121212121
Reserves
ReservesCr
1,1741,3661,6721,9872,4102,5812,7993,1673,6784,2124,7534,249
Current Liabilities
Current LiabilitiesCr
3826326688578911,0311,2031,2061,3431,4071,4771,422
Non Current Liabilities
Non Current LiabilitiesCr
39475575224207201161152277251232
Total Liabilities
Total LiabilitiesCr
1,6172,0662,4162,9413,5473,8404,2244,5565,1935,9176,5025,925
Current Assets
Current AssetsCr
1,4511,8932,2652,7613,2053,4873,8533,0253,2464,7633,7713,921
Non Current Assets
Non Current AssetsCr
1661731511803423533711,5301,9481,1542,7312,004
Total Assets
Total AssetsCr
1,6172,0662,4162,9413,5473,8404,2244,5565,1935,9176,5025,925

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2493071534996267279488931,2131,0121,319
Investing Cash Flow
Investing Cash FlowCr
-77-155-215-257-401-72-396-148-416182-371
Financing Cash Flow
Financing Cash FlowCr
-80-90-102-143-217-582-637-639-745-925-1,066
Net Cash Flow
Net Cash FlowCr
9162-16599873-8610752269-118
Free Cash Flow
Free Cash FlowCr
2262871365046117049048601,1659601,307
CFO To PAT
CFO To PAT%
97.4111.038.1110.8105.6105.2118.794.1101.071.585.0
CFO To EBITDA
CFO To EBITDA%
68.277.329.182.582.878.987.174.183.559.769.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2493071534996267279488931,2131,0121,319
Investing Cash Flow
Investing Cash FlowCr
-77-155-215-257-401-72-396-148-416182-371
Financing Cash Flow
Financing Cash FlowCr
-80-90-102-143-217-582-637-639-745-925-1,066
Net Cash Flow
Net Cash FlowCr
9162-16599873-8610752269-118
Free Cash Flow
Free Cash FlowCr
2262871365046117049048601,1659601,307
CFO To PAT
CFO To PAT%
97.4111.038.1110.8105.6105.2118.794.1101.071.585.0
CFO To EBITDA
CFO To EBITDA%
68.277.329.182.582.878.987.174.183.559.769.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0039,85811,57915,50632,84331,85137,61146,93457,26065,30355,08656,364
Price To Earnings
Price To Earnings
39.235.628.934.455.446.147.149.447.746.235.534.1
Price To Sales
Price To Sales
3.83.43.54.28.07.47.78.79.810.17.97.8
Price To Book
Price To Book
8.47.16.87.713.512.213.314.715.515.411.513.2
EV To EBITDA
EV To EBITDA
25.122.120.122.940.732.132.237.438.037.728.027.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.139.240.841.841.943.144.543.042.543.144.444.4
OPM
OPM%
13.913.715.916.418.521.422.122.524.826.427.328.3
NPM
NPM%
9.89.512.212.214.516.016.217.820.522.122.423.0
ROCE
ROCE%
33.531.636.934.931.134.337.039.143.142.942.552.6
ROE
ROE%
21.419.923.722.424.426.528.329.832.533.432.538.7
ROA
ROA%
15.813.416.615.316.718.018.920.823.123.923.927.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,0039,85811,57915,50632,84331,85137,61146,93457,26065,30355,08656,364
Price To Earnings
Price To Earnings
39.235.628.934.455.446.147.149.447.746.235.534.1
Price To Sales
Price To Sales
3.83.43.54.28.07.47.78.79.810.17.97.8
Price To Book
Price To Book
8.47.16.87.713.512.213.314.715.515.411.513.2
EV To EBITDA
EV To EBITDA
25.122.120.122.940.732.132.237.438.037.728.027.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
42.139.240.841.841.943.144.543.042.543.144.444.4
OPM
OPM%
13.913.715.916.418.521.422.122.524.826.427.328.3
NPM
NPM%
9.89.512.212.214.516.016.217.820.522.122.423.0
ROCE
ROCE%
33.531.636.934.931.134.337.039.143.142.942.552.6
ROE
ROE%
21.419.923.722.424.426.528.329.832.533.432.538.7
ROA
ROA%
15.813.416.615.316.718.018.920.823.123.923.927.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Market CapitalizationMkt CapCr56,36446,20717,64015,4199,2787,9287,384
Close PriceClose₹26,525.002,727.603,856.006,167.505,589.503,442.403,206.10
IndustryIndustryPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk DrugsPharma MNC Bulk Drugs
Price To EarningsPE34.1040.8520.5386.7624.4328.3520.26
Price To SalesPS7.8311.116.655.936.228.104.05
RevenueRevenueCr7,1984,1592,6542,6021,4919791,822
Revenue Growth TTMRev Gr TTM%7.2%12.1%11.8%29.7%16.1%22.7%-5.7%
PAT Growth TTMPAT Gr TTM%9.5%20.0%2.4%-10.8%23.8%28.4%2.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews